Hematologic Malignancy
📧 Sign up to get email alerts when something new happens for Hematologic Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
Clinical trial NCT04557709, sponsored by MD Anderson Cancer Center, evaluating major complication rate in cancer patients with neutropenic f…
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant [NA]
A clinical trial evaluating TCRαβ/CD19-depleted stem cell grafts for transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors [Phase 2]
Phase 2 trial of itacitinib for treating steroid-refractory immune-related adverse events from immune checkpoint inhibitors has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-08-31Clinical Trial Update: Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation [Phase 2]
A Phase 2 trial evaluating TXA127 (Angiotensin 1-7) to improve engraftment in pediatric cord blood transplantation was withdrawn.